The agency says it has taken various steps to ensure the privacy of participants’ data. 

The nationwide experiment will initially include around 100,000 volunteers.

A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.

Millions of measurements from 23 people who consumed extra calories every day for a month reveal changes in proteins, metabolites, and gut microbiota that accompany shifts in body mass.

Michael Christman oversaw the organization’s well-known biobank and pioneered a personalized medicine initiative.

Zebrafish larvae transplanted with patients’ tumors respond as their human donors do to chemotherapy.

Measuring PD-L1 levels was a great start. Now we need to quantify more protein biomarkers, assess the tumor mutational landscape, and examine immune cell signatures, too.

Meet some of the people featured in the April 2017 issue of The Scientist.

The challenges of adapting drug development to the age of personalized therapies encourage collaboration among industry players.

With few resources and hesitant investors, basic scientists must rely on clinicians, patient advocates, and their own keen eye for biological connections.